Wegovy-Maker Novo Nordisk to Spend More Than $2 Billion Boosting Production in France

Novo Nordisk said it will invest more than $2 billion in its French production site as it seeks to meet rising demand for its blockbuster obesity and diabetes treatments.

Related Keywords

Paris ,France General ,France ,Denmark ,French ,Danish , ,Reuters ,Novo Nordisk ,File Photo ,Pharmaceuticals ,Anti Depressants ,Healthcare Life Sciences ,Specialized Drugs Medications ,Hormone Products ,Diabetes Drugs ,European Union Countries ,Europe ,Mediterranean Countries ,Western Europe ,Output Production ,Capacity Facilities ,Labor Personnel ,Corporate Industrial News ,Products Services ,Recruitment ,Political General News ,Diabetes ,Health ,Medical Conditions ,Content Types ,Factiva Filters ,C Ampe Industry News Filter ,Synd ,Wsj Pro Com ,Novob Ko ,Dk Novo B ,Output ,Production ,Capacity ,Facilities ,Labor ,Personnel ,Corporate ,Industrial News ,Products ,Services ,Political ,General News ,Healthcare ,Life Sciences ,Specialized Drugs ,Medications ,